In 2023, Bayer advanced its pipeline with eight investigational new drug (IND) applications. Four assets are expected to advance to phase II by the end of 2024. High Yield Savings Offers .

Bayer Leverkusen are in advanced talks to sign Liverpool defender Jarell Quansah with an agreement close; Leverkusen ...

Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) said on Wednesday that the U.S. FDA has approved its blockbuster oral hormone blocker, darolutamide, in combination therapy, to treat metastatic hormone-sensitive ...

Bayer HealthCare has introduced Bayer Advanced aspirin, which can relieve pain twice as fast as previous Bayer aspirin tablets, according to the company. Practice Specialties ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today initiation of a Phase I clinical trial with 225 Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed ...

Celebrating 50 years of Vietnam-Germany diplomatic relations, Bayer stands as a German company with a significant ...

Jonathan Tah is in advanced talks to join Bayern Munich as a free agent after his Bayer Leverkusen contract expires this summer. The 29-year-old defender confirmed in April that he would leave ...